( NASDAQ-SMALL:AEMD )

News from Aethlon Medical, Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Feb 12, 2018, 06:32 ET Aethlon Medical To Present at the American Society for Microbiology Biothreats Meeting

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Feb 01, 2018, 16:15 ET Aethlon Medical Announces Fiscal 2018 Third Quarter Results

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today...


Jan 29, 2018, 08:15 ET Aethlon Medical to Release Third Quarter Fiscal Year 2018 Financial Results and Host Conference Call on February 1, 2018

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it...


Jan 23, 2018, 08:15 ET Aethlon Medical Announces Validation Completion for European Patent Protecting Methods of Quantifying Exosomes

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Jan 18, 2018, 07:49 ET Aethlon Medical Announces Allowance of U.S. Patent that Broadens Protection for the Aethlon Hemopurifier® to Treat Viral Infections

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that...


Jan 10, 2018, 09:01 ET Sabrina Martucci Johnson Joins Aethlon Medical's Board of Directors

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the...


Nov 29, 2017, 07:45 ET Aethlon Medical Names Dr. Charles J. Fisher Chairman of the Board

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the...


Nov 09, 2017, 12:58 ET Dr. Charles J. Fisher, Jr. Joins Aethlon Medical's Board of Directors

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the...


Nov 02, 2017, 16:15 ET Aethlon Medical Announces Fiscal 2018 Second Quarter Results

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced...


Oct 30, 2017, 07:30 ET Aethlon Medical to Release Financial Results for the Second Quarter Fiscal Year 2018 and Host Conference Call on November 2, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it...


Oct 16, 2017, 07:15 ET Aethlon Medical Announces Large-Scale Production Collaboration

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Oct 11, 2017, 08:15 ET Aethlon Medical to Present at the 2017 BIO Investor Forum

Aethlon Medical, Inc. (Nasdaq:AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that...


Oct 10, 2017, 13:28 ET Aethlon Medical Announces Compliance With Nasdaq Listing Criteria

Aethlon Medical, Inc. (NASDAQ: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced that...


Oct 02, 2017, 06:00 ET Aethlon Medical Announces Pricing of $6 Million Public Offering

Aethlon Medical, Inc. (NASDAQ:AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announces the pricing...


Sep 14, 2017, 07:30 ET Aethlon Medical Receives National Cancer Institute Contract Award

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Sep 12, 2017, 07:30 ET Aethlon Medical Receives Expedited Access Pathway Designation from FDA to Accelerate U.S. Access to the Hemopurifier® as a Treatment for Life-Threatening Viruses

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Sep 06, 2017, 09:12 ET Aethlon Medical to Present at the 19th Annual Rodman & Renshaw Global Investment Conference on September 11, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced that...


Aug 10, 2017, 16:15 ET Aethlon Medical Announces Fiscal 2018 First Quarter Results

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today...


Aug 03, 2017, 08:00 ET Aethlon Medical To Release Financial Results for the First Quarter Fiscal Year 2018 and Host Conference Call on August 10, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced it...


Jul 19, 2017, 07:11 ET Aethlon Medical Announces the Grant of a U.S. Patent Protecting Methods of Capturing MHC Antigen Associated Exosomes

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Jun 28, 2017, 16:15 ET Aethlon Medical Announces Fiscal 2017 Results

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced...


Jun 26, 2017, 08:15 ET Aethlon Medical To Release 2017 Fiscal Year End Financial Results and Host Conference Call on June 28, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced it...


Jun 14, 2017, 08:00 ET Aethlon Medical To Present Clinical Study Results at The BIO International Convention

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, announced today that...


Jun 06, 2017, 08:00 ET Aethlon Medical, Inc., Announces Upcoming Presentation and Webcast at the LD Micro Invitational Conference on June 6, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced that...


May 24, 2017, 08:00 ET Aethlon to Present at the LD Micro Invitational Conference on June 6, 2017

Aethlon Medical, Inc. (Nasdaq: AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense today announced James...